CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand

The aim of the study was to explore factors associated with CD4 percentage (CD4%) reconstitution following treatment interruptions (TIs) of antiretroviral therapy (ART).

[1]  C. Giaquinto,et al.  Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV‐1 infection 2015: optimizing health in preparation for adult life , 2015, HIV medicine.

[2]  R. Callard,et al.  Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial , 2017, Front. Immunol..

[3]  R. Callard,et al.  Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy , 2017, The Pediatric infectious disease journal.

[4]  R. Ferrand,et al.  Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges , 2016, Tropical medicine & international health : TM & IH.

[5]  C. Rouzioux,et al.  Interruption of cART in Clinical Practice Is Associated With an Increase in the Long-Term Risk of Subsequent Immunosuppression in HIV-1-Infected Children , 2014, The Pediatric infectious disease journal.

[6]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[7]  S. Madhi,et al.  Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial , 2013, The Lancet.

[8]  R. Callard,et al.  Predicting Patterns of Long-Term CD4 Reconstitution in HIV-Infected Children Starting Antiretroviral Therapy in Sub-Saharan Africa: A Cohort-Based Modelling Study , 2013, PLoS medicine.

[9]  J. Ananworanich,et al.  Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions , 2013, AIDS.

[10]  R. Callard,et al.  Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. , 2012, The Journal of infectious diseases.

[11]  Brian C. Zanoni,et al.  Sex differences in HIV RNA level and CD4 cell percentage during childhood. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  S. Spector,et al.  CD4+ Lymphocyte-Based Immunologic Outcomes of Perinatally HIV-Infected Children During Antiretroviral Therapy Interruption , 2011, Journal of acquired immune deficiency syndromes.

[13]  J. Ananworanich,et al.  Response to planned treatment interruptions in HIV infection varies across childhood , 2010, AIDS.

[14]  A. d’Arminio Monforte,et al.  Response to combination antiretroviral therapy: variation by age , 2008, AIDS.

[15]  Akihiko Saitoh,et al.  Clinical Outcomes After an Unstructured Treatment Interruption in Children and Adolescents With Perinatally Acquired HIV Infection , 2008, Pediatrics.

[16]  Dart Trial Team.  Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/μl , 2008 .

[17]  A. Monforte,et al.  Determinants of Virologic and Immunologic Outcomes in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) Study , 2007, Journal of acquired immune deficiency syndromes.

[18]  J. Ragnaud,et al.  Intermittent antiretroviral therapy in patients with controlled HIV infection. , 2007, AIDS.

[19]  J Darbyshire,et al.  CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.

[20]  Matthias Cavassini,et al.  CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial , 2006, The Lancet.

[21]  Roger Salamon,et al.  CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial , 2006, The Lancet.

[22]  N. Klein,et al.  Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. , 2002, The Journal of infectious diseases.

[23]  W. Boehler,et al.  Almer, A , 2001 .

[24]  M. Leal,et al.  CD4+ and CD8+ T lymphocyte regeneration after anti‐retroviral therapy in HIV‐1‐infected children and adult patients , 2000, Clinical and experimental immunology.

[25]  C. Giaquinto,et al.  Features of children perinatally infected with HIV-1 surviving longer than 5 years Italian Register for HIV Infection in Children , 1994, The Lancet.

[26]  O. Commissioner.  King's College Hospital , 1857, British medical journal.